New Lab Testing Results for Recent Dragon Pharma Batches

We're releasing another round of verified, third-party lab test results covering multiple Dragon Pharma batches recently received at our facility. These tests were performed on sealed vials and tablets to confirm accuracy, potency, and consistency before new stock goes into circulation.

Below is the full report:

Peptide Batches – Tested November 2025

Dragon Pharma GHK-CU lab test 2025-11-10 showing 55.10 mg per vial
55.10 mg
Dragon Pharma Ipamorelin/Tesamorelin lab test 2025-11-10 result
5.47 mg/5.33 mg
Dragon Pharma GHRP-6 lab test 2025-11-07 result
2025-11-07
10.38 mg
Dragon Pharma CJC No Dac/Ipamorelin lab test 2025-11-07 result
5.93 mg/4.96 mg
Dragon Pharma GHRP-2 lab test 2025-11-07 result
2025-11-07
5.88 mg

Non-Peptide Products – Tested October 2025

Dragon Pharma Enantat 400 lab test 2025-10-02 showing 418.88 mg/ml
418.88 mg/ml
Dragon Pharma Enclomiphene lab test 2025-10-16 result
25.19 mg/tab
Dragon Pharma SLU-PP-332 lab test 2025-10-16 result
534.91 mcg/tab

These results show consistent overfill across all tested batches, maintaining Dragon Pharma's commitment to transparency and accuracy. More lab data will be published as new results become available.

Nov 11, 2025 British Dragon

News

How to Use Crypto Payments ?
How to Use Crypto Payments ?

Wondering how to use Crypto payment methods on British Dragon store ? Here is a guide on how to proceed easily with crypto payments.

Significant Testabol Propionate Phase II Efficacy Results
Significant Testabol Propionate Phase II Efficacy Results

British Dragon Pharma announced new Testabol Propionate (bioidentical testosterone propionate) Phase II clinical trial efficacy data will be presented today at the annual meeting of the American Society for Reproductive Medicine (ASRM) in Philadelphia.

Gynecomastia  - A Common Side Effect Of Steroid Use
April 3, 2024 British Dragon
Gynecomastia - A Common Side Effect Of Steroid Use

Gynecomastia is generally the medical term used to refer to a development of breast tissues in male steroid users. This commonly occurs when a male steroid user is presented with the unusually very high level of estrogen in the body, out of steroid use.

Customer Reviews

Please leave your review on products or service below.
Thank you beforehand.

Write a Review View Reviews

Add to Cart - Product(s)

Close Button
Empty

Total Cost: